B cells and B cell directed therapies in CNS inflammation

B08

B cells are an important therapeutic target in MS. While anti-CD20 therapy (depleting B cells) is beneficial in MS, targeting the B cell survival factors B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL) with atacicept worsened MS. The reasons for this apparent paradox are unclear, but indicate that the BAFF-APRIL system influences MS in a way that has not yet been understood. We aim to investigate the molecular and cellular basis of mechanism of action of different B cell directed therapies that are currently in use or being developed. In detail, we intend to analyze effects of different B cell directed therapies in peripheral and intrathecal compartments both in MS patients and in B cell dependent animal models including a spontaneous disease model featuring formation of autoantibodies and a Th17 adoptive transfer model featuring formation of submeningeal ectopic lymphoid follicles. These questions will guide our research::

    1. Why did blocking of BAFF and APRIL by atacicept worsen MS?
    2. What are the mechanistic details of anti-CD20 therapy?
    3. Inhibition of Bruton’s Tyrosine Kinase (BTK) is a promising novel therapeutic strategy in MS. How does the inhibition of BTK influence neuroinflammation?

 

 

 

 

 

 

 

 

 

 

 

Laurent et al., Nat Commun., 2015

 

Principal Investigators:

Prof. Dr. med. Edgar Meinl
Institut für klinische Neuroimmunologie
LMU München
edgar.meinl@med.uni-muenchen.de

Dr. rer nat. Anneli Peters
Institut für klinische Neuroimmunologie
LMU München
anneli.peters@med.uni-muenchen.de

News

Wed, 22/11/2023
Hybrid seminar on ‘The origins and consequences of multiple slerosis’
Munich. Prof. Lars Fugger from the Nuffield Department of Clinical Neurosciences at the University of Oxford will give a hybrid seminar on ‘The origins and consequences of multiple slerosis’ in the large auditorium at the TranslaTUM in MUNICH. The talk is organized by the TRR 355 and will be streamed via the TRR 355 seminar […]...more
Wed, 23/08/2023
Neurology Webinar on human brain T cells in health and multiple sclerosis
Muenster. The SFB 128 is happy welcome Joost J.F.M. Smolders, MD, PhD , head of MS Center ErasMS and Neuroimmunology Brain (NIB) Research Group at the Department of Immunology of the Erasmus University Medical Center (Erasmus MC), as lecturer at the Muenster Neurology Webinar. His talk is entitled “Unique features of human brain T cells […]...more
Thu, 03/08/2023
New Date: Neurology Webinar – How much gut needs the brain
Muenster. In January 2024, Prof. Anne-Katrin Pröbstel, Head of the Interdisciplinary Autoimmune Clinic at the University Hospital of Basel, will visit Muenster to give insights into the microbiota-immune crosstalk in neuroonflammation. Her presentation – which ois part of the Muenster Neurology Webinar – will be live-streamed. Time: Wednesday, January 24, 2024 Place: Online at zoom. […]...more